ResMed Inc. Health Care
Medical Sleep Apnea Software

$32.81 0.28 (0.86%)

High $32.86	Low $32.55	Trades 6,994	Turnover $36,021,783	Volume 1,098,777
30 June 2023 at 4:12pm

Market Cap (2-Oct) $45,857,808,384 (13th)	Close (30-Jun) $32.81 0 (0%)	Volume (30-Jun) 1,098,777	Shortsold (28-Sep) 2,352,375 (0.40%) (347th)
52w High $42.84	52w Low $25.42	P/E 18.76	EPS 1.49
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) 1	News Articles (7d) 1+

Short Interest

ASIC data, 28 Sep 2026

% Shorted

0.40% 0.00

vs 0.41% prior report

Most Shorted Rank

347th

of 704 shorted ASX stocks

Peak Short

3.10%

Oct 2014

Days to Cover

1.5

at 50d avg vol

View full short position history →

	Subject
	RMD Article: ‘Could be next Cochlear or ResMed’: heart device maker wins FDA approval
	1 (current) 2 3
	RMD Article: Sleep device giant ResMed says Trump tariffs will boost profits
	RMD Article: ResMed downplays Ozempic disruption fears as sales beat forecasts
	RMD Article: ResMed says sales growth defies weight-loss fears
	RMD Article: ASX to dive, ResMed ups dividend; Macquarie eyes hybrid issue
	RMD Article: ASX to dive, ResMed ups dividend; Block upgrades guidance
	RMD Article: Who are the highest paid ASX 200 CEOs?
	RMD Article: ASX gains, Collins Foods leaps 9pc, Paladin tumbles
	RMD Article: ResMed sinks as drug trial sparks Ozempic-style sell-off
	RMD Article: How Sage Capital is making money from other investors’ panic
	RMD Article: ASX stocks at risk from Ozempic – and ResMed isn’t one of them
	RMD Article: ASX to rise; Sayona cuts staff, Domino’s revokes guidance
	RMD Article: ASX charts fifth session of gains, led by miners; Domino’s sinks 30pc
	RMD Article: Why Australia’s biggest and oldest LIC defied the Ozempic sell-off
	RMD Article: Hedge fund LHC buys ResMed, bets against sceptics
	RMD Article: This fundie is betting against the ResMed sceptics
	RMD Article: Why Chris Kourtis just bought CSL and ResMed
	RMD Article: Beware of the Ozempic hype and its irrational market outcomes
	RMD Article: Unloved healthcare stocks can reinvent themselves
	RMD Article: Obesity drug sell-offs based on ‘guess work’
	RMD Article: ASX falls; Star sinks 15pc; ResMed jumps on Goldman report
	RMD Article: Why Hamish Tadgell just bought back into ResMed
	RMD Article: Why Hamish Tadgell just bought back into ResMed
	RMD Article: Why the Ozempic revolution matters to ASX investors
	RMD Article: ASX to slip; UBS cuts ResMed outlook; Macquarie flags 1Q24 hit
	RMD Article: ResMed short sellers see an opportunity with the rise of Ozempic
	RMD Article: ASX rallies to close higher; CBA buoys big four; Suncorp, ResMed sink
	RMD Article: You’re probably paying too much for CBA and CSL stocks
	RMD Article: ASX falls; Resmed, Suncorp, Block shares tumble
	RMD Article: ASX closes higher but ends the week down 1pc
	RMD Article: ASX ends the session higher but posts first weekly loss in four
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: FORM SD
	RMD Ann: Update - Dividend/Distribution - RMD
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: FORM 10Q for Qtr ended March, 2023
	RMD Article: How fewer smartphone shipments boosted ResMed’s sales
	RMD Ann: Dividend/Distribution - RMD
	RMD Ann: ResMed Announces Results for the Third Quarter of FY2023
	RMD Ann: RMD to Report Third Quarter Fiscal 2023 Results
	RMD Article: ResMed among Goldman’s picks if US economy falters
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: Company Secretary Appointment/Resignation
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: Update - Dividend/Distribution - RMD
	RMD Ann: Statement of CDIs on issue - RMD
	RMD Ann: FORM 10Q for Qtr ended December, 2022
	RMD Article: ResMed hits $1.4b in quarterly revenue
	RMD Ann: Dividend/Distribution - RMD
	RMD Ann: Chairman Appointment/Resignation

End of Day Prices

Date	Close	Volume	Change
02-Oct	$31.79	943,703	+0.24 (0.76%)
01-Oct	$31.55	1,146,553	-0.43 (1.34%)
30-Sep	$31.98	605,536	+0.30 (0.95%)
29-Sep	$31.68	847,222	+0.04 (0.13%)
28-Sep	$31.64	577,118	+0.06 (0.19%)
25-Sep	$31.58	705,983	-0.12 (0.38%)
24-Sep	$31.70	681,026	+0.09 (0.28%)
23-Sep	$31.61	607,796	+0.06 (0.19%)
22-Sep	$31.55	779,979	-0.11 (0.35%)
21-Sep	$31.66	911,163	-0.21 (0.66%)
18-Sep	$31.87	1,357,133	-0.17 (0.53%)
17-Sep	$32.04	1,426,745	+0.14 (0.44%)
16-Sep	$31.90	1,568,648	+0.53 (1.69%)
15-Sep	$31.37	1,870,620	+0.87 (2.85%)
14-Sep	$30.50	746,092	+0.19 (0.63%)
10 up, 5 down, and 0 flat days

ResMed Inc. Health Care Medical Sleep Apnea Software

Short Interest

Followers

Prices

Announcements

End of Day Prices

ResMed Inc. Health Care
Medical Sleep Apnea Software